Find a trial

BG-75098-101

A study of bg-75098 alone and in combination with other agents in adults with advanced solid tumors.

Locations Wesley

Diagnosis Advanced solid tumours

C6461006

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Locations Wesley

Diagnosis Urotherlial cancer, Bladder cancer

C6461008

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Locations Wesley

Diagnosis Liver cancer

DESTINY-Ovarian01

A Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer

Locations Wesley

Diagnosis Ovarian cancer

TREVI-OC-01 / D8991C00001

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer (TREVI-OC-01)

Locations Wesley

Diagnosis Ovarian cancer

PEAK-1

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

Locations Hobart, Adelaide, Wesley, Chermside

Diagnosis Kidney cancer